NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2031210322

Registered date:16/09/2021

Special Drug Use-results Survey of RIONA Tablets (Pregnant Patients with Iron Deficiency Anemia)

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedIron deficiency anaemia
Date of first enrollment01/10/2021
Target sample size100
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeDrug safety in pregnant patient with iron deficiency anaemia
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderFemale
Include criteria(1) Pregnant patients using Riona for the first time for iron deficiency anaemia (2) Patients must provide informed consent before the start
Exclude criterianone

Related Information

Contact

Public contact
Name Patient Safety and Pharmacovigilance Dept.
Address 3-4-1, Nihonbashi-Honcho 3-chome, Chuo-ku, Tokyo, Japan Tokyo Japan 103-0023
Telephone +81-3-6635-3504
E-mail pms-pharma@jt.com
Affiliation Japan Tobacco Inc.
Scientific contact
Name Patient Safety and Pharmacovigilance Dept.
Address 3-4-1, Nihonbashi-Honcho 3-chome, Chuo-ku, Tokyo, Japan Tokyo Japan 103-0023
Telephone +81-3-6635-3504
E-mail pms-pharma@jt.com
Affiliation Japan Tobacco Inc.